Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients

Trial Profile

Retrospective Cohort Study of Rebif® Use in Pediatric MS Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Aug 2013

At a glance

  • Drugs Interferon beta-1a (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Acronyms REPLAY
  • Sponsors EMD Serono
  • Most Recent Events

    • 20 Apr 2012 Data will be presented at the American Academy of Neurology's 64th Annual Meeting (AAN) [posters P04.119; P04.120], according to a Merck Serono media release.
    • 08 Mar 2012 Actual patient number (309) added as reported by ClinicalTrials.gov.
    • 08 Mar 2012 Actual end date (August 2011) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top